Literature DB >> 4609330

The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.

N H Neff, H Y Yang, J A Fuentes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4609330

Source DB:  PubMed          Journal:  Adv Biochem Psychopharmacol        ISSN： 0065-2229


× No keyword cloud information.
  7 in total

1.  Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.

Authors:  B K Koe
Journal:  Experientia       Date:  1975-06-15

2.  Brain serotonin and 5-hydroxyindoleacetic acid concentrations and serotonin synthesis following tetrahydro-beta-carboline administration in mice.

Authors:  N S Buckholtz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

Review 3.  Physiological and pathological changes in tissue monoamine oxidase activity.

Authors:  M B Youdim; M Holzbauer
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

4.  Variation in monoamine oxidase activity in rat brain crude mitochondrial fractions prepared by rate zonal centrifugation.

Authors:  M B Youdim
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

Review 5.  Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition.

Authors:  M B Youdim; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  Effects of L-deprenyl on human growth hormone secretion.

Authors:  M Koulu; R Lammintausta
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex.

Authors:  R Mishra; D D Gillespie; M B Youdim; F Sulser
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.